Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency.

Hirano M, Garone C, Haas R, Paradas C, Scaglia F, Rebollo Mesa I, Chiang C, Colson AO, VanMeter S, Domínguez-González C

Open source

DOI
10.1093/braincomms/fcag201
Published
2026
Container
Brain communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/braincomms/fcag201,
  title = {Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency.},
  author = {Hirano M and Garone C and Haas R and Paradas C and Scaglia F and Rebollo Mesa I and Chiang C and Colson AO and VanMeter S and Domínguez-González C},
  year = {2026},
  journal = {Brain communications},
  doi = {10.1093/braincomms/fcag201},
  url = {https://doi.org/10.1093/braincomms/fcag201}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency.
AU  - Hirano M
AU  - Garone C
AU  - Haas R
AU  - Paradas C
AU  - Scaglia F
AU  - Rebollo Mesa I
AU  - Chiang C
AU  - Colson AO
AU  - VanMeter S
AU  - Domínguez-González C
PY  - 2026
JO  - Brain communications
DO  - 10.1093/braincomms/fcag201
UR  - https://doi.org/10.1093/braincomms/fcag201
ER  - 

APA

M, H., C, G., R, H., C, P., F, S., I, R. M., C, C., AO, C., S, V., & C, D. (2026). Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency.. Brain communications. https://doi.org/10.1093/braincomms/fcag201

Source records